Abstract
Dietary phenylalanine restriction in phenylketonuria (PKU) patients is usually mandatory in order to prevent cognitive impairment. The influence of a low-protein diet on growth has raised concerns in families and caregivers. This paper aims to investigate the growth in PKU patients treated with a low-protein diet including supplementation of amino acids and other nutrients according to standard protocols.
We performed a single-center, cross-sectional study on growth in pediatric PKU patients (n = 51) treated with low-protein diet over a 20-month period. Height of healthy siblings (n = 44) and target height, calculated based on parents’ height, served as controls.
No statistically significant differences were found comparing mean height z-scores between patients and siblings (p = 0.261). Patients <12 years showed a reduction in mean height z-scores compared to the target height (p = 0.020), whereas postpubertal patients ≥12 years did not differ significantly in height z-scores compared to the target height (p = 0.071). Healthy siblings’ height did not differ from target height in neither age group (p = 0.100/p = 0.301).
Our results suggest that PKU patients treated with low-protein diet can achieve normal growth with patients making up the leeway after puberty. While prepubertal patients were shorter than expected based on their target height, older patients were within their expected target height. This study indicates that current practice of low-protein diet in PKU patients allows normal growth.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Acosta PB, Yannicelli S, Singh R, Mofidi S, Steiner R, DeVincentis E, Jurecki E, Bernstein L, Gleason S, Chetty M (2003) Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc 103:1167–1173
Ahring K, Bélanger-Quintana A, Dokoupil K, Ozel HG, Lammardo AM, MacDonald A, Motzfeldt K, Nowacka M, Robert M, van Rijn M (2009) Dietary management practices in phenylketonuria across European centres. Clin Nutr 28:231–236
Belanger-Quintana A, Martínez-Pardo M (2011) Physical development in patients with phenylketonuria on dietary treatment: a retrospective study. Mol Genet Metab 104:480–484
Blau N (2016) Genetics of phenylketonuria: then and now. Hum Mutat 37:508–515
Blau N, van Spronsen FJ, Levy HL (2010) Phenylketonuria. Lancet 376:1417–1427
Blau N, Hennermann JB, Langenbeck U, Lichter-Konecki U (2011) Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab 104:S2–S9
Blau N, Shen N, Carducci C (2014) Molecular genetics and diagnosis of phenylketonuria: state of the art. Expert Rev Mol Diagn 14:655–671
Boas F (1940) Changes in bodily form of descendants of immigrants. Am Anthropol 42:183–189
Braegger C, Jenni O, Konrad D, Molinari L (2011) Neue Wachstumskurven für die Schweiz. Paediatrica 22:9–11
Burgard P, Ullrich K, Ballhausen D, Hennermann JB, Hollak CEM, Langeveld M, Karall D, Konstantopoulou V, Maier EM, Lang F, Lachmann R, Murphy E, Garbade S, Hoffmann GF, Kolker S, Lindner M, Zschocke J (2017) Issues with European guidelines for phenylketonuria. Lancet Diabetes Endocrinol 5:681–683
Cole TJ (2003) The secular trend in human physical growth: a biological view. Econ Human Biol 1:161–168
Diamond A, Prevor MB, Callender G, Druin DP (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. In: Monographs of the Society for Research in Child Development. University of Chicago Press, Chicago, pp i–206
Dobbelaere D, Michaud L, Debrabander A, Vanderbecken S, Gottrand F, Turck D, Farriaux J (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J Inherit Metab Dis 26:1–11
Evans S, Daly A, Chahal S, MacDonald J, MacDonald A (2016) Food acceptance and neophobia in children with phenylketonuria: a prospective controlled study. J Hum Nutr Diet 29:427–433
Gorber SC, Tremblay M, Moher D, Gorber B (2007) A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev 8:307–326
Grimes DA, Schulz KF (2005) Compared to what? Finding controls for case-control studies. Lancet 365:1429–1433
Hoeksma M, Van Rijn M, Verkerk PH, Bosch AM, Mulder MF, de Klerk JB, De Koning TJ, Rubio-Gozalbo E, De Vries M, Sauer PJ (2005) The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J Inherit Metab Dis 28:845–854
Huemer M, Huemer C, Möslinger D, Huter D, Stöckler-Ipsiroglu S (2007) Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis 30:694–699
Kaplan BA (1954) Environment and human plasticity. Am Anthropol 56:780–800
Lasker GW (1952) Environmental growth factors and selective migration. Hum Biol 24:262
Loeber JG (2007) Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis 30:430–438
MacDonald A, Daly A, Davies P, Asplin D, Hall S, Rylance G, Chakrapani A (2004) Protein substitutes for PKU: what’s new? J Inherit Metab Dis 27:363–371
McBurnie M, Kronmal R, Schuett V, Koch R, Azeng C (1991) Physical growth of children treated for phenylketonuria. Ann Hum Biol 18:357–368
Mereu T (1967) Adequacy of low-phenylalanine diet. Am J Dis Child 113:522–523
National Institutes of Health Consensus Development Panel (2001) National Institutes of Health Consensus Development Conference statement: phenylketonuria: screening and management, October 16–18, 2000. Pediatrics 108:972–982
Niedhammer I, Bugel I, Bonenfant S, Goldberg M, Leclerc A (2000) Validity of self-reported weight and height in the French GAZEL cohort. Int J Obes 24:1111–1118
Rocha JC, van Spronsen FJ, Almeida MF, Ramos E, Guimarães JT, Borges N (2013) Early dietary treated patients with phenylketonuria can achieve normal growth and body composition. Mol Genet Metab 110:S40–S43
Schaefer F, Burgard P, Batzler U, Rupp A, Schmidt H, Gilli G, Bickel H, Bremer H (1994) Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr 83:534–541
Scriver CR (2007) The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 28:831–845
Shapiro HL, Hulse FS (1939) Migration and environment: a study of the physical characteristics of the Japanese immigrants to Hawaii and the effects of environment on their descendants. Oxford University Press, Oxford
Tanner JM (1986) 1 Normal growth and techniques of growth assessment. Clin Endocrinol Metab 15:411–451
Theile H, Graustein I, Wässer S, Bührdel P (1990) Effect of dietary non-compliance on development in phenylketonuria – studies of 14-year-old patients. Padiatr Padol 25:19–23
Thöny B, Blau N (2006) Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat 27:870–878
van Spronsen FJ, van Wegberg AM, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Gizewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, Trefz FK, van Rijn M, Walter JH, MacDonald A (2017) Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 5:743–756
Verkerk P, Van Spronsen F, Smit G, Sengers R (1994) Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee. Arch Dis Child 71:114–118
Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA (2014) Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 16:188–200
Weglage J, Brämswig J, Koch H, Karassalidou S, Ullrich K (1994) Growth in patients with phenylketonuria. Eur J Pediatr 153:537–538
Weglage J, Pietsch M, Feldmann R, Koch H-G, Zschocke J, Hoffmann G, Muntau-Heger A, Denecke J, Guldberg P, Güttler F (2001) Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res 49:532–536
Widaman KF (2009) Phenylketonuria in children and mothers: genes, environments, behavior. Curr Dir Psychol Sci 18:48–52
Williams RA, Mamotte CD, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29:31
Zaffanello M, Zamboni G, Tatò L (2002) Growth parameters in newborns with hyperphenylalaninaemia. Paediatr Perinat Epidemiol 16:274–277
Acknowledgement
We are obliged to all patients and their families who took part in this study. We would also like to thank Nathalie Wunderli and Priska Wuhrbach for their help in measuring the patients’ height. We also gratefully acknowledge the access to height percentiles elaborated by the Department of Developmental Paediatrics of the University Children’s Hospital Zurich under the direction of Prof. Dr. O. Jenni.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Daniela Karall
Appendices
Take-Home Message
After a prepubertal delay in growth, PKU patients treated with low-protein diet can achieve normal growth similar to their sibling and in accordance with their target height.
Compliance with Ethics Guidelines
Jana Matic, Nina A. Zeltner, and Johannes Häberle declare that they have no conflict of interest.
Jana Matic and Johannes Häberle have planned the study and performed the data collection. Jana Matic, Nina A. Zeltner, and Johannes Häberle have performed data analysis. Jana Matic has prepared the first draft of the manuscript and figures, which were revised by all authors. All authors have seen and approved the final version of the manuscript.
Rights and permissions
Copyright information
© 2018 Society for the Study of Inborn Errors of Metabolism (SSIEM)
About this chapter
Cite this chapter
Matic, J., Zeltner, N.A., Häberle, J. (2018). Normal Growth in PKU Patients Under Low-Protein Diet in a Single-Center Cross-Sectional Study. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 43. JIMD Reports, vol 43. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2018_92
Download citation
DOI: https://doi.org/10.1007/8904_2018_92
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-58613-6
Online ISBN: 978-3-662-58614-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)